Thioredoxin-1 (Trx-1) is a 12 kDa redox
protein that is overexpressed in a large number of human
tumors. Elevated Trx-1 is associated with increased
tumor cell proliferation, inhibited apoptosis, aggressive
tumor growth, and decreased patient survival. The molecular mechanisms for the promotion of
tumorigenesis by Trx-1 are not known. PTEN is a major
tumor suppressor of human
cancer that acts by hydrolyzing membrane
phosphatidylinositol (PtdIns)-3-phosphates, thus, preventing the activation of the survival signaling
kinase Akt by PtdIns-3-kinase. We show that Trx-1 binds in a redox dependent manner to PTEN to inhibit its PtdIns-3-phosphatase activity which results in increased Akt activation in cells. Molecular docking and site-specific mutation studies show that the binding of Trx-1 to PTEN occurs through a
disulfide bond between the active site Cys(32) of Trx-1 and Cys(212) of the C2 domain of PTEN leading to steric interference by bound Trx-1 of the catalytic site of PTEN and of the C2
lipid membrane-binding domain. The results of the study suggest that the increased levels of Trx-1 in human
tumors could lead to functional inhibition of PTEN
tumor suppressor activity providing an additional mechanism for
tumorigenesis with loss of PTEN activity.